Request Your Free Guide Now:

"Accelerate Your Biologics Program with High‑Titer, Fast‑Turnaround CLD Solutions"

Accelerate IND timelines with high‑productivity, IP‑friendly CHO cell line development.

ProBio’s Cell Line Development (CLD) platform helps innovators reach IND milestones faster with a high‑performance, biotech‑friendly solution designed for speed, productivity, and reliability.

Key Advantages

• Fast CLD timelines: 10–14 weeks from gene synthesis to Primary Cell Bank (PCB)–stage clones.
• High pre‑process titers: Strong productivity early, reducing downstream risk.
• Proprietary CHO platforms: Includes a FUT8‑knockout ADCC‑enhanced line.
• IP‑friendly: Royalty‑free model with IP‑free afucosylated antibody production.
• Stable & scalable: Robust clone performance supports smooth scale‑up.
• Flexible for multiple modalities: mAbs, bispecifics, Fc‑engineered molecules, recombinant proteins.

Explore the flyer to see how ProBio’s high‑titer performance and accelerated workflows can speed your path to IND readiness.

Offered Free by: ProBio
See All Resources from: ProBio